Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,095 USD | +1.17% |
|
+3.82% | +24.59% |
07-12 | UBS Raises Price Target on Regeneron Pharmaceuticals to $1,250 From $1,124, Maintains Buy Rating | MT |
07-11 | Morgan Stanley Trims Price Target on Regeneron Pharmaceuticals to $1,182 From $1,183 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.59% | 117B | |
+20.38% | 127B | |
+25.44% | 27.67B | |
-17.93% | 20.33B | |
-15.17% | 16.79B | |
-14.83% | 15.63B | |
+12.68% | 14.84B | |
-47.10% | 14.65B | |
+56.49% | 14.43B | |
+149.89% | 12.49B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals Completes Acquisition of Decibel Therapeutics